María José Lecumberri

Functional systemic CD4 immunity is required for clinical responses to PD‐L1/PD‐1 blockade therapy

Miren Zuazo, Hugo Arasanz, G. Fernández-Hinojal et al. · EMBO Molecular Medicine · 2019 · 216 citations · Full text

Life Sciences, Immunology, Oncology +17

Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study

Yolanda Escobar, Gerardo Cajaraville, Juan Antonio Virizuela et al. · Supportive Care in Cancer · 2015 · 81 citations · Full text

Medicine, Oncology, Pharmacology +13

Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment

Javier Martínez‐Trufero, Dolores Isla, Juan Carlos Adansa et al. · British Journal of Cancer · 2010 · 74 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer

Ana Bocanegra, G. Fernández-Hinojal, Miren Zuazo-Ibarra et al. · International Journal of Molecular Sciences · 2019 · 74 citations · Full text

Life Sciences, Immunology, Oncology +17

Determinants of patient satisfaction with care in a Spanish oncology Day Hospital and its relationship with quality of life

Juan Ignacio Arrarás, José Juan Illarramendi, A. Viúdez et al. · Psycho-Oncology · 2013 · 44 citations

Medicine, Oncology, End-of-life Care +16